These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4432944)

  • 1. Letter: Possible effects of combining phenothiazines.
    Davidson J
    Am J Psychiatry; 1974 Dec; 131(12):1408-9. PubMed ID: 4432944
    [No Abstract]   [Full Text] [Related]  

  • 2. High vs standard dosage fluphenazine HCL in acute schizophrenia.
    Donlon PT; Meadow A; Tupin JP; Wahba M
    J Clin Psychiatry; 1978 Nov; 39(11):800-4. PubMed ID: 363702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lergotrile on schizophrenia & drug induced parkinsonism.
    Small JG; Kellams JJ; Milstein V; Klapper M; Lemberger L
    Commun Psychopharmacol; 1977; 1(5):461-7. PubMed ID: 23919
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Flexibility in the use of fluphenazine decanoate.
    Marriott P; Grigor J; Hiep A
    Br J Psychiatry; 1975 Feb; 126():204. PubMed ID: 1131475
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of oral fluphenazine on Huntington's chorea.
    Whittier JR; Korenyi C
    Int J Neuropsychiatry; 1968 Feb; 4(1):1-3. PubMed ID: 4230793
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
    Höflich G; Burghof KW; Kasper S; Möller HJ
    Nervenarzt; 1994 Mar; 65(3):202-5. PubMed ID: 7909917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 9. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
    Kurland AA; Dim BH; Olsson JE
    Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting response to phenothiazines: the right drug for the right patient.
    Galbrecht CR; Klett CJ
    J Nerv Ment Dis; 1968 Aug; 147(2):173-83. PubMed ID: 5677325
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
    Abramova LI; Gushanskiĭ EL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):419-24. PubMed ID: 3705854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triiodothyronine and phenothiazines in schizophrenia.
    Wolpert A; Yaryura-Tobias JA; White L; Merlis S
    Dis Nerv Syst; 1969 Jul; 30(7):487-9. PubMed ID: 5810556
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of schizophrenic psychoses with Lyorodin].
    Schulz HD; Kluge HH; Korda W; Kube B
    Psychiatr Neurol Med Psychol (Leipz); 1977 Jun; 29(6):360-6. PubMed ID: 918199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maintenance therapy with oenanthate of fluphenazine, associated with thioridazine and thymoanaleptics. Use of small doses].
    Schnetzler JP; Naveau C
    Ann Med Psychol (Paris); 1971 May; 1(5):800-6. PubMed ID: 5559010
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
    Berliner J
    Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with Melleril-Retard.
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970; 12(3):245-6. PubMed ID: 5457439
    [No Abstract]   [Full Text] [Related]  

  • 18. [Striatal hypersensitivity to neuroleptics. Therapeutic difficulties and medico-legal aspects].
    Antoine C; Chiffoleau A; Baudot S; Bourin M; Larousse C; Besancon G
    Therapie; 1988; 43(5):437. PubMed ID: 3227508
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with fluphenazine decanoate in psychoses].
    Náhunek K; Rodová A; Svestka J
    Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum thioridazine level and its antipsychotic effect measured by a general scale of psychopathology evaluation in patients with schizophrenia].
    Sidorowicz S; Chyczewski T; Janicka B; Sanecka B; Slepecka J; Wasik A
    Psychiatr Pol; 1986; 20(2):96-101. PubMed ID: 3786592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.